Latest news

Debiopharm releases results of 3 key oncology compound programs at the 2019 American Association for Cancer Research (AACR) Conference in…

GenePOC obtains FDA clearance for its GenePOC™ Strep A test

ACTEON has entered into exclusive negotiations to acquire the Dental Division of VILLA SISTEMI MEDICALI

Debiopharm International SA Initiates a Clinical Trial Phase II study evaluating afabicin in Bone and Joint Infections

Debiopharm International SA Initiates FUZE, a Clinical Trial Phase II study evaluating Debio 1347 in Advanced Solid Tumors harboring an…

Challenge pour la Qualité de vie du patient 2019 : l’appel à projets est ouvert !

Debiopharm Group regains the commercial rights to Trelstar® (Triptorelin pamoate) and looks for new partners in North America

Grand succès du 3e Challenge pour la Qualité de vie des patients

GenePOC® launches its GenePOC® CDiff test in Canada